⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1796762 | 0.87 | — | — | |
| SCHEMBL686193 | 0.82 | — | — | |
| SCHEMBL31596328 | 0.82 | — | — | |
| SCHEMBL18207697 | 0.82 | — | — | |
| SCHEMBL16878556 | 0.80 | — | — | |
| SCHEMBL16878586 | 0.78 | — | — | |
| SCHEMBL345019 | 0.78 | — | — | |
| SCHEMBL16878199 | 0.76 | — | — | |
| SCHEMBL16877939 | 0.76 | — | — | |
| SCHEMBL2138130 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 801 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954758-A | Synthesis method of natural product Hypermonone G | 贵州大学 | 2025-05-09 | — | — | CN | claimed |
| EP-4543544-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | Biogen MA Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| CN-119866338-A | Tyrosine kinase 2 inhibitors and uses thereof | 渤健马萨诸塞州股份有限公司 | 2025-04-22 | — | — | CN | claimed |
| WO-2023250064-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | BIOGEN MA INC. (US) | 2023-12-28 | — | — | WO | claimed |
| US-20230101747-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | SCHRÖDINGER, INC. | 2023-03-30 | — | — | US | claimed |
| EP-4069369-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | Schrödinger, Inc. (US) | 2022-10-12 | — | — | EP | claimed |
| WO-2021113492-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | SCHRÖDINGER, INC. (US) | 2021-06-10 | — | — | WO | claimed |
| EP-2714773-B1 | SILICIC ACID (HETERO) POLYCONDENSATES COMPRISING ORGANICALLY POLYMERISABLE GROUPS AND EITHER SULPHONATE GROUPS OR SULPHATE GROUPS, ORGANIC POLYMERISATES PRODUCED THEREFROM, AND A METHOD FOR PRODUCING SAID POLYCONDENSATES | FRAUNHOFER GES FORSCHUNG (DE) | 2018-08-22 | — | — | EP | claimed |
| EP-1015469-B1 | BI- AND TRI-CYCLIC NUCLEOSIDE, NUCLEOTIDE AND OLIGONUCLEOIDE ANALOGUES | EXIQON AS (DK) | 2005-04-13 | — | — | EP | claimed |
| US-20040254158-A1 | Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders | BRISTOL-MYERS SQUIBB COMPANY | 2004-12-16 | — | — | US | claimed |
| EP-0358290-B1 | 2-Oxa-bicyclo[2.2.1]heptane derivatives and medicines containing these compounds | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-02-03 | — | — | EP | claimed |
| EP-4749365-A1 | CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2026-05-27 | — | — | EP | disclosed |
| CN-122072437-A | Chemically amplified negative resist composition and resist pattern forming method | 信越化学工业株式会社 | 2026-05-22 | — | — | CN | disclosed |
| EP-4727939-A1 | 5-(CINNOLIN-6-YL)THIAZOLE COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS | Prothena Biosciences Limited (IE) | 2026-04-22 | — | — | EP | disclosed |
| US-12568960-B2 | Adjuvant combinations as foliar uptake accelerator for herbicidal compositions | BAYER AKTIENGESELLSCHAFT (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-0358290-A1 | 2-Oxa-bicyclo[2.2.1]heptane derivatives and medicines containing these compounds | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-03-14 | — | — | EP | disclosed |
| EP-0286167-A2 | Hard-surface cleaning compositions | THE PROCTER & GAMBLE COMPANY (US) | 1988-10-12 | — | — | EP | disclosed |
| EP-0260619-A2 | Liquid-cristal copolyethers | Montedison S.p.A. (IT) | 1988-03-23 | — | — | EP | disclosed |
| US-4554365-A | Process for preparing oxabicycloalkane compounds | SHELL OIL COMPANY (US) | 1985-11-19 | — | — | US | disclosed |
| EP-0135225-A2 | Process for preparing oxabicycloalkane compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1985-03-27 | — | — | EP | disclosed |